PreOperative Performance develops instrumentation that can establish a quality standard for diffusion MR Imaging, allowing clinicians to confidently plan neurological interventions. Quality-assured data enables better outcomes and improved quality-of-life for patients, successful surgeries for clinical teams, and lower costs for healthcare providers. Additionally, PreOperative Performance’s vision is to expand what’s diagnostically possible from non-invasive imaging and supports system level approaches to protecting patients and reducing errors.
Founder and CEO
Southern Ontario Pharmaceutical & Health Innovation Ecosystem (SOPHIE) Program brings together Innovation Factory’s commercialization services with the Synapse Life Science Consortium’s strategic network to leverage access to Hamilton’s unique life sciences capabilities and research expertise.